{
    "root": "ddb7fed1-c449-4473-95c1-9aa4c68de5cf",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metoprolol Succinate",
    "value": "20250401",
    "ingredients": [
        {
            "name": "METOPROLOL SUCCINATE",
            "code": "TH25PD4CCB"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "ETHYLCELLULOSE (20 MPA.S)",
            "code": "BJG0S321QY"
        },
        {
            "name": "METHYLENE CHLORIDE",
            "code": "588X2YUY0A"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A",
            "code": "NX76LV5T8J"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "metoprolol succinate , beta-adrenergic blocker indicated treatment : • hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) • angina pectoris . ( 1.2 ) • heart failure , reduce risk cardiovascular mortality heart failure hospitalizations patients heart failure ( 1.3 )",
    "contraindications": "• administer daily . titrate weekly longer intervals needed tolerated . ( 2 ) • hypertension : starting dose 25 mg 100 mg. ( 2.1 ) • angina pectoris : starting dose 100 mg. ( 2.2 ) • heart failure : starting dose 12.5 mg 25 mg. ( 2.3 ) • switching immediate-release metoprolol metoprolol succinate extended-release tablets : total daily dose metoprolol succinate extended-release tablets . ( 2 )",
    "warningsAndPrecautions": "metoprolol succinate extended-release tablets , usp 200 mg tablets : white white , oval shape , biconvex film coated tablet breakline one side debossed 'a200 ' side . ndc 72162-1859-1 : 100 tablets bottle ndc 72162-1859-5 : 500 tablets bottle ndc 72162-1859-0 : 1000 tablets bottle store 25°c ( 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) . [ usp controlled room temperature . ] repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "metoprolol succinate extended-release tablets contraindicated severe bradycardia , second- third- degree heart block , cardiogenic shock , decompensated heart failure , sick sinus syndrome ( unless permanent pacemaker place ) , patients hypersensitive component product .",
    "indications_original": "Metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Angina Pectoris. ( 1.2 ) • Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure ( 1.3 )",
    "contraindications_original": "• Administer once daily. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) • Hypertension: Starting dose is 25 mg to 100 mg. ( 2.1 ) • Angina Pectoris: Starting dose is 100 mg. ( 2.2 ) • Heart Failure: Starting dose is 12.5 mg or 25 mg. ( 2.3 ) • Switching from immediate-release metoprolol to metoprolol succinate extended-release tablets: use the same total daily dose of metoprolol succinate extended-release tablets. ( 2 )",
    "warningsAndPrecautions_original": "Metoprolol Succinate Extended-Release Tablets, USP\n                  \n                  200 mg tablets: White to off white, oval shape, biconvex film coated tablet with breakline on one side and debossed with 'A200' on other side.\n                  \n                     NDC 72162-1859-1: 100 Tablets in a BOTTLE\n                     NDC 72162-1859-5: 500 Tablets in a BOTTLE\n                     NDC 72162-1859-0: 1000 Tablets in a BOTTLE\n                  \n                  Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.]\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second- or third- degree heart block, cardiogenic shock, decompensated heart failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product."
}